Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
The SARS-CoV-2 infection is associated with pulmonary coagulopathy, which determines the deposition of fibrin in the air spaces and lung parenchyma. The resulting lung lesions compromise patient pulmonary function and increase mortality, or end in permanent lung damage for those who have recovered f...
Saved in:
Main Authors: | Anna Maria Piras (Author), Ylenia Zambito (Author), Maurizio Lugli (Author), Baldassare Ferro (Author), Paolo Roncucci (Author), Filippo Mori (Author), Alfonso Salvatore (Author), Ester Ascione (Author), Marta Bellini (Author), Roberto Crea (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment
by: Lucia Vizzoni, et al.
Published: (2023) -
Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability
by: Chiara Migone, et al.
Published: (2024) -
Assessment of the availability of repurposed orphan drugs in India.
by: Khujith Rajueni, et al.
Published: (2023) -
Assessment of the availability of repurposed orphan drugs in India
by: Khujith Rajueni, et al.
Published: (2023) -
Impact of Different Mucoadhesive Polymeric Nanoparticles Loaded in Thermosensitive Hydrogels on Transcorneal Administration of 5-Fluorouracil
by: Angela Fabiano, et al.
Published: (2019)